A carregar...

Low-Dose Rituximab Therapy for Antibody-Mediated Rejection in a Highly Sensitized Heart-Transplant Recipient

Antibody-mediated rejection is the B-cell–mediated production of immunoglobulin G antibody against the transplanted heart. The currently available therapies for antibody-mediated rejection have had marginal success, and chronic manifestations of rejection can result in an increased risk of graft vas...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Aggarwal, Ashim, Pyle, Joseph, Hamilton, John, Bhat, Geetha
Formato: Artigo
Idioma:Inglês
Publicado em: Texas Heart Institute 2012
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3528252/
https://ncbi.nlm.nih.gov/pubmed/23304051
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!